Related references
Note: Only part of the references are listed.Early Corneal Innervation and Trigeminal Alterations in Parkinson Disease: A Pilot Study
Alessandro Arrigo et al.
CORNEA (2018)
An updated review of Parkinson's disease genetics and clinicopathological correlations
M. Ferreira et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Reduction of GAPDH in Lenses of Parkinson's Disease Patients: A Possible New Biomarker
Alexa Klettner et al.
MOVEMENT DISORDERS (2017)
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease
John M. Lee et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)
Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease
Erik A. Williams et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)
Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness
Eva Csosz et al.
JOURNAL OF PROTEOMICS (2017)
Loss of Melanopsin-Expressing Ganglion Cell Subtypes and Dendritic Degeneration in the Aging Human Retina
Gema Esquiva et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond
Chiara La Morgia et al.
FRONTIERS IN NEUROLOGY (2017)
Evaluation of Progressive Visual Dysfunction and Retinal Degeneration in Patients With Parkinson's Disease
Maria Satue et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease
Keiko Nakamura et al.
NEUROPATHOLOGY (2016)
Alpha synuclein and crystallin expression in human lens in Parkinson's disease
Alexa Klettner et al.
MOVEMENT DISORDERS (2016)
A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease
Shahnaz Miri et al.
PARKINSONISM & RELATED DISORDERS (2016)
Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers
Gergo Kallo et al.
PLOS ONE (2016)
Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies
Diana L. Price et al.
SCIENTIFIC REPORTS (2016)
A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography
Samantha Slotnick et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
Thomas G. Beach et al.
NEUROPATHOLOGY (2015)
Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration
Violeta Gomez-Vicente et al.
PLOS ONE (2015)
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
Scarlet Gallegos et al.
FRONTIERS IN NEUROSCIENCE (2015)
α-Synuclein in the Inner Retina in Parkinson Disease
Ivan Bodis-Wollner et al.
ANNALS OF NEUROLOGY (2014)
Beta-Amyloid, Phospho-Tau and Alpha-Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients
Cheng-Ying Ho et al.
BRAIN PATHOLOGY (2014)
Venturing Into the No-Man's Land of the Retina in Parkinson's Disease
Ivan Bodis-Wollner et al.
MOVEMENT DISORDERS (2014)
Extracellular α-synuclein-a novel and crucial factor in Lewy body diseases
He-Jin Lee et al.
NATURE REVIEWS NEUROLOGY (2014)
Low clinical diagnostic accuracy of early vs advanced Parkinson disease Clinicopathologic study
Charles H. Adler et al.
NEUROLOGY (2014)
Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects
Thomas G. Beach et al.
NEUROSCIENCE LETTERS (2014)
Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases
Nicolas Cuenca et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2014)
Ophthalmological Features of Parkinson Disease
Barbara Nowacka et al.
MEDICAL SCIENCE MONITOR (2014)
Electrophysiology and Optical Coherence Tomography to Evaluate Parkinson Disease Severity
Elena Garcia-Martin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
Douglas G. Walker et al.
EXPERIMENTAL NEUROLOGY (2013)
The Ubiquitin-Proteasome System in Retinal Health and Disease
Laura Campello et al.
MOLECULAR NEUROBIOLOGY (2013)
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
Neil K. Archibald et al.
MOVEMENT DISORDERS (2011)
Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina
Julian Esteve-Rudd et al.
NEUROBIOLOGY OF DISEASE (2011)
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2010)
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Retinopathy in Parkinson disease
Ivan Bodis-Wollner
JOURNAL OF NEURAL TRANSMISSION (2009)
The Sun Health Research Institute Brain Donation Program: Description and experience, 1987-2007
Thomas G. Beach et al.
CELL AND TISSUE BANKING (2008)
Specificity and regulation of casein kinase-mediated phosphorylation of α-synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Visual dysfunction in Parkinson disease without dementia
EY Uc et al.
NEUROLOGY (2005)
Morpholoical impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease
N Cuenca et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Share Paper
